COFS vs BCAL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 12, 2026

COFS

33.9
AI Score
VS
BCAL Wins

BCAL

49.5
AI Score

Investment Advisor Scores

COFS

34score
Recommendation
AVOID NEW MONEY

BCAL

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric COFS BCAL Winner
Forward P/E 8.15 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -0.6% -5.2% COFS
Earnings Growth 0.0% -10.4% COFS
Tradestie Score 33.9/100 49.5/100 BCAL
Profit Margin 32.2% 32.2% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD BCAL

Relative Price Performance (Last 90 Days)

COFS 1M: +12.9% · 3M: +6.5% BCAL 1M: +2.7% · 3M: +1.1%

Current Technical Phase

COFS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 64

RSI (14): 64.3 · Price: $36.67

BCAL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.8% over 20 days), RSI 54

RSI (14): 54.1 · Price: $21.99

Fundamentals Snapshot

Metric COFS BCAL
Market Cap — —
Forward P/E 9.6 11.7
Trailing P/E 10.0 12.2
Revenue (TTM) — —
Revenue Growth 0.0% -0.1%
Gross Margin 1.0% 1.0%
Operating Margin 0.4% 0.5%
EPS 3.67 1.81
Dividend Yield 0.03% 0.02%

Frequently Asked Questions

Based on our detailed analysis, BCAL is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.